<div id="readability-page-1"><div>                     <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/aura-biosciences-inc-logo-1200x675.png/query-dj0yMDIxMTEyMzA3NTMxNw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1200" height="675" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/aura-biosciences-inc-logo-1200x675.png/query-dj0yMDIxMTEyMzA3NTMxNw"/>Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Janet Jill Hopkins sold 17,109 shares of Aura Biosciences stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $5.42, for a total value of $92,730.78. Following the completion of the sale, the insider owned 252,685 shares of the company's stock, valued at approximately $1,369,552.70. The trade was a 6.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink.</p><h2>Aura Biosciences Trading Down 0.5%</h2><ul><li>3 Small-Cap Stocks Ready to Deliver Significant Growth</li></ul><p>Shares of NASDAQ:AURA opened at $5.50 on Tuesday. Aura Biosciences, Inc. has a 1-year low of $4.34 and a 1-year high of $9.78. The stock has a market capitalization of $349.25 million, a P/E ratio of -2.84 and a beta of 0.45. The business has a 50-day moving average price of $5.99 and a two-hundred day moving average price of $6.23. </p><p>Aura Biosciences (NASDAQ:AURA - Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($0.40) EPS for the quarter, topping the consensus estimate of ($0.46) by $0.06.  As a group, equities analysts predict that  Aura Biosciences, Inc. will post -1.66 EPS for the current year. </p><h2>Institutional Inflows and Outflows</h2><hr/><hr/><p>A number of hedge funds have recently added to or reduced their stakes in AURA. Frazier Life Sciences Management L.P. acquired a new stake in  Aura Biosciences in the 2nd quarter valued at $31,926,000.  Long Focus Capital Management LLC boosted its stake in shares of  Aura Biosciences by 30.8% during the 1st quarter. Long Focus Capital Management LLC now owns 3,319,582 shares of the company's stock worth $19,453,000 after buying an additional 781,808 shares during the last quarter.  Vanguard Group Inc. grew its holdings in shares of  Aura Biosciences by 16.7% in the 3rd quarter. Vanguard Group Inc. now owns 2,890,503 shares of the company's stock valued at $17,863,000 after acquiring an additional 413,001 shares in the last quarter.  Franklin Resources Inc. increased its position in shares of  Aura Biosciences by 5.9% in the second quarter. Franklin Resources Inc. now owns 2,340,810 shares of the company's stock valued at $14,653,000 after acquiring an additional 130,221 shares during the last quarter.  Finally, Nantahala Capital Management LLC raised its holdings in  Aura Biosciences by 67.1% during the second quarter. Nantahala Capital Management LLC now owns 2,117,697 shares of the company's stock worth $13,257,000 after acquiring an additional 850,000 shares in the last quarter. Institutional investors own  96.75% of the company's stock. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several analysts have commented on AURA shares. Weiss Ratings  reiterated a &#34;sell (d-)&#34; rating on shares of Aura Biosciences in a research report on Tuesday, November 11th. HC Wainwright  reiterated a &#34;buy&#34; rating and issued a $22.00 price objective on shares of Aura Biosciences in a research report on Wednesday, August 13th. Finally, Zacks Research raised Aura Biosciences from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, August 19th. One analyst  has rated the stock with a Strong Buy rating, three have given a Buy rating, one  has assigned  a Hold rating and one  has issued  a Sell rating to the stock. Based on data from MarketBeat, Aura Biosciences presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $20.50.</p><p><b>Get Our Latest Analysis on Aura Biosciences</b></p><h2>Aura Biosciences Company Profile</h2><p> (Get Free Report)</p><p>Aura Biosciences, Inc, a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates.</p><h2>See Also</h2><ul><li>Five stocks we like better than Aura Biosciences</li><li>How to Invest in Tech Stocks and Top Tech Stocks to Consider</li><li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li><li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion </li><li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li><li>What Are the FAANG Stocks and Are They Good Investments?</li><li>How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVVSQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVVSQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].</em></p>                     <div>                         <p>Insider Buying or Selling at Aura Biosciences?</p>                         <p>Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aura Biosciences and related companies.</p>                                                                       </div>                                                               <div>                         <p>From Our Partners</p><div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250910122802_pushai-10.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250910122802_pushai-10.jpg"/></p><div><p>Claim $3,452/Mo in AI Equity Checks</p><p>The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies...  In turn, enfo...</p><p><span>Angel Publishing</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTc3Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTc3Mg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/20250718113332_unnamed.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="512" height="288" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/20250718113332_unnamed.png"/></p><div><p>Trump’s national nightmare is here</p><p>Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...</p><p><span>Porter &amp; Company</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTcyOA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTcyOA"/></p></div></div><div><p></p><div><p>Billionaire Gold Investor Just Doubled His Stake-At a Price You Could Still Match</p><p>Gold legends-Eric Sprott, Goldcorp founder Rob McEwen, and Kinross founder Bob Buchan...each own a sizable sta...</p><p><span>i2i Marketing Group, LLC</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE0Mw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE0Mw"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251013195604_pushtrumpnew-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251013195604_pushtrumpnew-3.jpg"/></p><div><p>NEW LAW: Congress Approves Setup For Digital Dollar?</p><p>Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0  But according to Rep. Marjorie Taylor ...</p><p><span>Goldco Precious Metals</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTg0Mw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTg0Mw"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250915160222_pushdollar01.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20250915160222_pushdollar01.jpg"/></p><div><p>Gold Lockdown</p><p>Why Wall Street is piling into the “Debasement Trade”  Wall Street has been making headlines lately for pili...</p><p><span>Stansberry Research</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTgwMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTgwMQ"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://s3.amazonaws.com/assets.oxfordclub.com/emails/external_images/OXF_SEVEN_ALEX_STOCKS.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1920" height="1080" original-src="https://imageproxy.pbkrs.com/https://s3.amazonaws.com/assets.oxfordclub.com/emails/external_images/OXF_SEVEN_ALEX_STOCKS.jpg"/></p><div><p>He Called Nvidia at $1.10. Now, He Says THIS Stock Will…</p><p>A Millionaire With SEVEN Clicks?  $1,000 in just seven stocks in 2004 could have turned into a million-dolla...</p><p><span>The Oxford Club</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTc0Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNTc0Mg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251117103825_pushhands-820272640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251117103825_pushhands-820272640.jpg"/></p><div><p>They thought he was crazy when he said THIS on LIVE TV…</p><p>JC Parets — the same analyst who famously called the exact bottom of the 2022 bear market on live TV — is now ...</p><p><span>Trend Labs</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE1Ng?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE1Ng"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251117182254_pushtrumpnew-5.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20251117182254_pushtrumpnew-5.jpg"/></p><div><p>Trump did what?!</p><p>Trump’s family isn’t just dabbling in digital assets — they’ve built a multibillion-dollar crypto portfolio, s...</p><p><span>Weiss Ratings</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE1Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xNjE1Mg"/></p></div></div></div>                     </div>                 </div></div>

AURA

<p>Aura Biosciences insider Janet Jill Hopkins sold 17,109 shares at $5.42 each, totaling $92,730.78. Post-sale, she owns 252,685 shares, valued at $1,369,552.70, marking a 6.34% decrease in her position. The transaction was disclosed in an SEC filing. Aura Biosciences stock opened at $5.50, with a market cap of $349.25 million. Analysts have mixed ratings, with an average target price of $20.50.</p>

Insider Selling: Aura Biosciences (NASDAQ:AURA) Insider Sells 17,109 Shares of Stock